TFG Asset Management Welcomes Shareholder Support for Governance Reforms at Kolibri Global Energy

Kolibri Global Energy (KGEI) reported Q2 2026 revenue of $22.5M, up 109% YoY, driven by 46% higher production and 41% higher prices. Adjusted EBITDA rose 114% to $16.4M, while net income increased 200% to $8.5M. Production averaged 4,690 BOE per day, with oil prices at $95.08 per barrel. The company increased its borrowing base by 15% to $75M, with $30.5M in available liquidity. Management expects Q4 production to be the highest of the year.

Kolibri Global Energy reported Q2 2026 revenue net of royalties of $22.5 million, up from $10.8 million a year earlier, driven by 46% higher production to 4,690 BOEPD and 41% higher average prices. Net income rose to $8.5 million, with basic EPS $0.24. Adjusted EBITDA increased to $16.4 million. The company said it has $30.5 million available borrowing capacity after a May 2026 credit facility increase to $75 million.

Kolibri Global Energy Inc. reported Q2 2026 revenue net of royalties of $22.5 million, up from $10.8 million a year earlier, driven by 46% higher production to 4,690 BOEPD and 41% higher average prices. Net income rose to $8.5 million (basic EPS $0.24) and Adjusted EBITDA to $16.4 million. At June 30, 2026 it had $30.5 million available under a $75 million credit facility.

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.